Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | IDE | P14735 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10013660 | 1.00 | SMN1; SMN2 (0.48) | SMN1; SMN2MAPTNPC1PKMLMNA | |
| SCHEMBL10013644 | 0.78 | CSNK2A2 (0.50) | SMN1; SMN2MAPTNPC1PKMLMNA | |
| SCHEMBL10013636 | 0.77 | CSNK2A2 (0.49) | SMN1; SMN2MAPTNPC1PKMLMNA | |
| SCHEMBL10013655 | 0.77 | CSNK2A2 (0.43) | SMN1; SMN2MAPTNPC1PKMLMNA | |
| SCHEMBL13790975 | 0.76 | MEN1 (0.64) | SMN1; SMN2MAPTLMNATSHRPOLB | |
| SCHEMBL10013646 | 0.75 | CSNK2A2 (0.43) | SMN1; SMN2MAPTNPC1PKMLMNA | |
| SCHEMBL13350306 | 0.74 | CSNK2A2 (0.46) | SMN1; SMN2MAPTNPC1PKMLMNA | |
| SCHEMBL10013650 | 0.74 | CSNK2A2 (0.46) | SMN1; SMN2MAPTNPC1PKMLMNA | |
| SCHEMBL13350278 | 0.74 | CSNK2A2 (0.46) | SMN1; SMN2MAPTNPC1PKMLMNA | |
| SCHEMBL10013651 | 0.74 | CSNK2A2 (0.46) | SMN1; SMN2MAPTNPC1PKMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9709557-B2 | Anthraquinone based near IR emitting compounds and uses thereof | Life Technologies Corporation (US) | 2017-07-18 | — | — | US | disclosed |
| US-9709557-B2 | Anthraquinone based near IR emitting compounds and uses thereof | Life Technologies Corporation (US) | 2017-07-18 | — | — | US | disclosed |
| US-20150168383-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation | 2015-06-18 | — | — | US | disclosed |
| US-20150168383-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation | 2015-06-18 | — | — | US | disclosed |
| US-8999965-B2 | Anthraquinone based near IR emitting compounds and uses thereof | Life Technologies Corporation (US) | 2015-04-07 | — | — | US | disclosed |
| US-8999965-B2 | Anthraquinone based near IR emitting compounds and uses thereof | Life Technologies Corporation (US) | 2015-04-07 | — | — | US | disclosed |
| US-20120028249-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120028249-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation (US) | 2012-02-02 | — | — | US | disclosed |
| WO-2010062499-A2 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation (US) | 2010-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028249-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | ANTXR2, AAAS, IK | SMN1; SMN2 4791/4885MAPT 4419/4885NPC1 3302/4885 |
| US-20150168383-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | ANTXR2, AAAS, IK | SMN1; SMN2 4791/4885MAPT 4419/4885NPC1 3302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.